Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

AS101 reduces hair loss from chemotherapy.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

A complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide may help increase hair count in male pattern hair loss without side effects.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Ritlecitinib can help about 14,000 people with severe hair loss.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.